Stock events for Transcat, Inc. (TRNS)
Over the past six months, Transcat's stock price has been impacted by several events. Strong fiscal Q1 2026 results were reported with revenue up 14.6% and Adjusted EBITDA up 15.2%. The acquisition of Essco Calibration Laboratory expanded Transcat's geographic footprint and technical capabilities. Revenue for the first half of fiscal year 2026 increased due to both Service and Distribution segments. An analyst upgrade occurred as valuation normalized and revenue growth persisted. Fiscal Q3 2026 results showed robust top-line growth, but adjusted earnings per share fell short of estimates, with the stock showing a modest gain. Transcat shares gained 27% in the thirty days leading up to February 7, 2026, but the stock price decreased by 5.6% on March 6, 2026.
Demand Seasonality affecting Transcat, Inc.’s stock price
Demand for Transcat's products and services exhibits some seasonality, with capital expenditures and inventory stockpiling leading to short-term swings. The company has observed a decrease in demand for calibration services and its rental business within the distribution segment during December due to customers ramping up manufacturing and extended holiday closures. Service revenue typically picks up significantly in January following the holiday period. August has historically shown the highest probability of positive stock returns for TRNS, while September has the lowest.
Overview of Transcat, Inc.’s business
Transcat, Inc. is a leading provider of accredited calibration and laboratory instrument services, as well as a distributor of professional-grade test and measurement instruments, operating primarily within the Industrials sector. The company focuses on serving highly regulated industries where precision and compliance are critical, including life sciences, aerospace and defense, energy and utilities, and industrial manufacturing. The company operates through two main segments: the Service Segment, which offers accredited calibration and related services generating approximately 62% of revenue in fiscal year 2025, and the Distribution Segment, which sells and rents branded instruments and provides value-added services. Major products include a proprietary line of data loggers, calibration baths, and humidity generators, alongside instruments from brands like Extech, FLIR, Fluke, Keysight, and Megger.
TRNS’s Geographic footprint
Transcat, Inc. has a significant geographic footprint, with over 25 strategically located calibration laboratories across North America and Ireland. The company provides on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers throughout the United States, Puerto Rico, Canada, and Ireland.
TRNS Corporate Image Assessment
Transcat's brand reputation is built on being an indispensable partner for measurement integrity and quality control, fostering trust within highly regulated industries. The company emphasizes its ISO/IEC 17025 accreditation across its lab network, which is crucial for clients in sectors like aerospace, defense, and pharma. Transcat has a strong track record of consistent performance, having achieved 65 to 67 consecutive quarters of year-over-year service revenue growth.
Ownership
Transcat, Inc.'s ownership is primarily distributed among institutional investors and individual shareholders, with institutional investors holding a majority of the company's shares. Major institutional owners include Conestoga Capital Advisors, LLC, Neuberger Berman Group LLC, and BlackRock, Inc., among others. Insider ownership accounted for approximately 2.35% in April 2025, growing to around 2.9% by August 2025, with Lee D. Rudow, the President and CEO, holding 1.27% of the company's shares as of March 27, 2025. The general public holds about a 12% stake.
